13:29 Thu 17 May 2018
Arix Bioscience Plc - Result of AGM
Results of Annual General Meeting
Full details of the poll results are set out below and will also be available on the Company's website www.arixbioscience.com.
No |
RESOLUTION |
VOTES FOR |
% |
VOTES AGAINST |
% |
TOTAL VOTES |
% of ISC VOTED |
VOTES WITHHELD |
1 |
To receive the Directors' report and the accounts for the Company for the year ended |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
2 |
To approved the Directors' Remuneration Report for the year ended |
50,988,886 |
90.12 |
5,591,495 |
9.88 |
56,580,381 |
41.98% |
4,020 |
3 |
To re‐elect Dr |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
4 |
To re‐elect Professor |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
5 |
To re‐elect Dr |
51,655,214 |
91.29 |
4,929,188 |
8.71 |
56,584,402 |
41.99% |
0 |
6 |
To re‐elect Lord |
54,810,619 |
96.87 |
1,773,783 |
3.13 |
56,584,402 |
41.99% |
0 |
7 |
To re‐elect Professor |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
8 |
To re‐elect |
54,526,217 |
96.36 |
2,058,185 |
3.64 |
56,584,402 |
41.99% |
0 |
9 |
To re‐elect |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
10 |
To re‐elect David U'Prichard as a Director |
55,183,865 |
97.53 |
1,399,000 |
2.47 |
56,582,865 |
41.99% |
1,537 |
11 |
To elect |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
12 |
To elect |
56,582,865 |
100.00 |
0 |
0.00 |
56,582,865 |
41.99% |
1,537 |
13 |
To re‐appoint |
55,185,402 |
97.53 |
1,399,000 |
2.47 |
56,584,402 |
41.99% |
0 |
14 |
To authorise the |
56,584,402 |
100.00 |
0 |
0.00 |
56,584,402 |
41.99% |
0 |
15 |
To authorise the Directors to allot shares |
55,618,631 |
100.00 |
2,198 |
0.00 |
55,620,829 |
41.27% |
963,573 |
16 |
To authorise the Directors to disapply statutory pre‐ emption rights in respect of 5% of the Company's issued share capital |
53,013,611 |
95.32 |
2,605,020 |
4.68 |
55,618,631 |
41.27% |
965,771 |
17 |
To authorise the Directors to disapply statutory pre‐ emption rights in respect of an additional 5% of the Company's issued share capital |
51,614,611 |
92.80 |
4,004,020 |
7.20 |
55,618,631 |
41.27% |
965,771 |
18 |
To authorise the Company to buy back shares |
54,215,987 |
97.48 |
1,403,929 |
2.52 |
55,619,916 |
41.27% |
964,486 |
19 |
To authorise the Directors to call a general meeting other than an annual general meeting on not less than 14 clear days' notice |
56,581,832 |
100.00 |
2,570 |
0.00 |
56,584,402 |
41.99% |
0 |
Notes:
1. Any proxy arrangement which gave discretion to the Chairman has been included in the "for" totals.
2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
3. The number of voting shares in issue at
In accordance with Listing Rule 9.6.2, copies of resolutions passed at the Meeting concerning items other than ordinary business will shortly be available for inspection on the National Storage Mechanism, which can be accessed at www.hemscott.com/nsm.do
ENDS
Enquiries
For more information on Arix, please contact:
+44 (0) 20 7290 1055
+44 (0)20 7290 1072
+44 (0)20 3709 5700
About
For further information, please visit www.arixbioscience.com
This information is provided by RNS
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE